The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson’s disease
Acta Neuropathol Commun (2023) 11 (1), 72 DOI: 10.1186/s40478-023-01570-5
Molecular determinants of the crosstalk between endosomal microautophagy and chaperone-mediated autophagy
Cell Reports (2023) 42 (12), 113529 DOI: 10.1016/j.celrep.2023.113529
Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology
Science Advances (2023) 9 (19), eadf3775 DOI: 10.1126/sciadv.adf3775
Pharmacologic inhibition of NLRP3 reduces the levels of α-synuclein and protects dopaminergic neurons in a model of Parkinson's disease
Journal of Neuroinflammation (2023) 20 (1), 147 DOI: 10.1186/s12974-023-02830-w
Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storage
Nature Communications (2023) 14 (1), 1918 DOI: 10.1038/s41467-023-37561-2
Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer’s disease
Acta Neuropathologica Communications; https://doi.org/10.1186/s40478-020-01117-y
TDP-43–specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis
Neurology Neuroimmunology & Neuroinflammation; doi.org/10.1212/NXI.0000000000000937
Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease
Jama Neurology; doi:10.1001/jamaneurol.2020.3311
Decreased AQP4 Expression Aggravates ɑ-Synuclein Pathology in Parkinson’s Disease Mice, Possibly via Impaired Glymphatic Clearance
Springer Link; doi.org/10.1007/s12031-021-01836-4
Exogenous Alpha-Synuclein Evoked Parkin Downregulation Promotes Mitochondrial Dysfunction in Neuronal Cells. Implications for Parkinson’s Disease Pathology
Frontiers; doi.org/10.3389/fnagi.2021.591475